Shares of Bio-Techne Corp. TECH shed 2.04% to $58.73 Friday, on what proved to be an all-around poor trading session for the ...

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research ...

Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region ...

Shares of Bio-Techne Corp. TECH slipped 1.78% to $59.98 Tuesday, on what proved to be an all-around favorable trading session ...

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Proficio Capital Partners LLC increased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 13.6% in the 4th quarter, according to its most recent disclosure with the SEC. The ...

MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care ...

ALZpath, Inc. (ALZpath), a leading developer of diagnostic tools and solutions for Alzheimer's disease and related dementias, announced the addition of Samantha Budd Haeberlein, PhD, to its board ...

Shares of Charles River Laboratories International Inc. slipped 3.37% to $161.35 Tuesday, on what proved to be an all-around ...